Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis

被引:12
|
作者
Soni, Anisha [1 ]
Thiyagarajan, Arun [1 ]
Reeve, Joanne [2 ]
机构
[1] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England
[2] Acad Primary Care, Hull York Med Sch, Kingston Upon Hull, N Humberside, England
关键词
Benzodiazepines; deprescribing; meta-analysis; primary care; systematic review; Z-drugs; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED-TRIAL; OLDER; DISCONTINUATION; WITHDRAWAL; ADULTS;
D O I
10.1111/add.15997
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and Aims A total of 2.4 million adults in England were dispensed a benzodiazepine or Z-drug (BZRA) in 2017/18, and more than 250 000 patients in the UK take BZRAs beyond the recommended duration. Deprescribing is a clinician-guided process of withdrawing inappropriate drugs. This review aimed to evaluate the evidence base supporting the feasibility and clinical effectiveness of all forms of deprescribing initiatives used to discontinue long-term (>= 4 weeks) BZRAs. Method Systematic review of randomized controlled trials evaluating BZRAs deprescribing among adults in community, primary or outpatient settings. MEDLINE, Embase and PsycINFO were searched from inception to February 2021. Primary outcomes were successful discontinuation in the short (< 4 weeks) or long term (>= 4 weeks) and the occurrence of withdrawal symptoms, behavioural or psychological symptoms. Studies were categorized as pharmacological or non-pharmacological supported interventions. Study quality was assessed using the Cochrane risk-of-bias tool. Where appropriate, risk ratios (RRs), mean differences and 95% confidence intervals (CIs) were calculated, and Mantel-Haenszel methods using the random-effect meta-analysis was undertaken to calculate summary effect estimates. Results Ten studies were included (n = 1431 participants). Heterogeneity in study design and effect was observed. Benzodiazepines were successfully deprescribed when gradually tapered with non-pharmacological support compared with gradual tapering alone in the short term (n = 124; RR = 2.02; 95% CI = 1.41, 2.89) and long term (n = 123; RR = 2.45; 95% CI = 1.56, 3.85). Benzodiazepine deprescribing was more successful when supported by non-pharmacological methods versus routine care (n = 189; RR = 3.26; 95% CI = 2.36, 4.51). Quality of evidence reporting effectiveness was very low to low. Conclusions It may be feasible to deprescribe benzodiazepines depending on the process and support mechanisms employed.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 50 条
  • [31] Association of benzodiazepines, z-drugs, pregabalin, and melatonin with traffic accidents
    Osler, Merete
    Jorgensen, Martin Balslev
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 214 - 214
  • [32] The Feasibility and Effectiveness of Telenutrition for Remote Dietary Consultation: A Systematic Review and Meta-analysis
    Daud, Nur Liyana Hasnaa Mohd
    Nor, Noraishah Mohamed
    Jaafar, Nurul Hazirah
    Abu Bakar, Wan Azdie Mohd
    Shukri, Nor Azwani Mohd
    CURRENT RESEARCH IN NUTRITION AND FOOD SCIENCE, 2025, 13 (01) : 46 - 60
  • [33] The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis
    Lampl, Christian
    MaassenVanDenBrink, Antoinette
    Deligianni, Christina I.
    Gil-Gouveia, Raquel
    Jassal, Tanvir
    Sanchez-del-Rio, Margarita
    Reuter, Uwe
    Uluduz, Derya
    Versijpt, Jan
    Zeraatkar, Dena
    Sacco, Simona
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [34] The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis
    Christian Lampl
    Antoinette MaassenVanDenBrink
    Christina I. Deligianni
    Raquel Gil-Gouveia
    Tanvir Jassal
    Margarita Sanchez-del-Rio
    Uwe Reuter
    Derya Uluduz
    Jan Versijpt
    Dena Zeraatkar
    Simona Sacco
    The Journal of Headache and Pain, 24
  • [35] Gestational exposure to benzodiazepines or z-hypnotics and neurodevelopmental disorders in offspring: Systematic review and meta-analysis
    Andrade, Chittaranjan
    Varadharajan, Natarajan
    Bascarane, Sharmi
    Menon, Vikas
    ACTA PSYCHIATRICA SCANDINAVICA, 2024, 150 (02) : 65 - 77
  • [36] Prevalence of Use, Abuse and Dependence: Benzodiazepines, Z-drugs and Prescription Opioids
    Wolter, Dirk
    SUCHTTHERAPIE, 2020, 21 (02) : 66 - 75
  • [37] Spontaneous parasomnia adverse event reports associated with benzodiazepines and Z-drugs
    Scheer, Darren
    Nguyen, Anh Thy H.
    Schwartz, Skai
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 342 - 342
  • [38] Outpatient Prescribing Trends of Benzodiazepines and Z-drugs in a General Hospital in Singapore
    Lee, K.
    Kinson, R.
    Ang, L.
    Wong, K.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [39] Trends in use of benzodiazepines and Z-drugs in France from 2012 to 2020
    Benard-Laribiere, Anne
    Pambrun, Elodie
    Diop, Papa-Yatma
    Pariente, Antoine
    THERAPIE, 2023, 78 (06):
  • [40] Benzodiazepines and Z-Drugs - Analyses of Ambulatory Prescriptions from 2006 to 2015
    Verthein, Uwe
    Buth, Sven
    Holzbach, Ruediger
    Neumann-Runde, Eike
    Martens, Marcus-S.
    PSYCHIATRISCHE PRAXIS, 2019, 46 (07) : 399 - 405